These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Molecular biology of catecholamine-related enzymes in relation to Parkinson's disease. Nagatsu T; Ichinose H Cell Mol Neurobiol; 1999 Feb; 19(1):57-66. PubMed ID: 10079965 [TBL] [Abstract][Full Text] [Related]
9. Metabolism of tetrahydrobiopterin: its relevance in monoaminergic neurons and neurological disorders. Ichinose H; Nomura T; Sumi-Ichinose C Chem Rec; 2008; 8(6):378-85. PubMed ID: 19107867 [TBL] [Abstract][Full Text] [Related]
10. Microbial Rhodopsin Optogenetic Tools: Application for Analyses of Synaptic Transmission and of Neuronal Network Activity in Behavior. Glock C; Nagpal J; Gottschalk A Methods Mol Biol; 2015; 1327():87-103. PubMed ID: 26423970 [TBL] [Abstract][Full Text] [Related]
11. [Segawa disease (hereditary progressive dystonia with marked diurnal fluctuation-HPD) and abnormalities in pteridin metabolism]. Segawa M Rinsho Shinkeigaku; 1996 Dec; 36(12):1322-3. PubMed ID: 9128393 [TBL] [Abstract][Full Text] [Related]
12. A new knock-in mouse model of l-DOPA-responsive dystonia. Rose SJ; Yu XY; Heinzer AK; Harrast P; Fan X; Raike RS; Thompson VB; Pare JF; Weinshenker D; Smith Y; Jinnah HA; Hess EJ Brain; 2015 Oct; 138(Pt 10):2987-3002. PubMed ID: 26220941 [TBL] [Abstract][Full Text] [Related]
13. Lipid signaling: sleep, synaptic plasticity, and neuroprotection. Chen C; Bazan NG Prostaglandins Other Lipid Mediat; 2005 Sep; 77(1-4):65-76. PubMed ID: 16099392 [TBL] [Abstract][Full Text] [Related]
14. Altered presynaptic gene expression in transgenic mice producing dopamine in the pineal gland. Cho S; Hwang O; Baker H; Baik HH; Volpe BT; Son JH; Joh TH Synapse; 1999 Nov; 34(2):135-44. PubMed ID: 10502312 [TBL] [Abstract][Full Text] [Related]
15. Tyrosine hydroxylase deficiency causes progressive encephalopathy and dopa-nonresponsive dystonia. Hoffmann GF; Assmann B; Bräutigam C; Dionisi-Vici C; Häussler M; de Klerk JB; Naumann M; Steenbergen-Spanjers GC; Strassburg HM; Wevers RA Ann Neurol; 2003; 54 Suppl 6():S56-65. PubMed ID: 12891655 [TBL] [Abstract][Full Text] [Related]
17. Physiological effects of electroconvulsive therapy and transcranial magnetic stimulation in major depression. Szuba MP; O'Reardon JP; Evans DL Depress Anxiety; 2000; 12(3):170-7. PubMed ID: 11126192 [TBL] [Abstract][Full Text] [Related]
18. Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders: regulation of dopaminergic neural transmission by tyrosine hydroxylase protein at nerve terminals. Sumi-Ichinose C; Ichinose H; Ikemoto K; Nomura T; Kondo K J Pharmacol Sci; 2010; 114(1):17-24. PubMed ID: 20716859 [TBL] [Abstract][Full Text] [Related]